Chinese bidders evince interest in Johnson & Johnson's diabetes biz in potential $3-4b deal

Chinese bidders are circling a diabetes care business owned by the world’s largest healthcare company Johnson & Johnson in a deal that could fetch up to $4 billion, five people with direct knowledge told Reuters.